nodes	percent_of_prediction	percent_of_DWPC	metapath
Ziprasidone—HTR2C—metabolic syndrome X	0.648	1	CbGaD
Ziprasidone—HTR7—sympathetic nervous system—metabolic syndrome X	0.00739	0.0861	CbGeAlD
Ziprasidone—HTR2A—arteriole—metabolic syndrome X	0.00723	0.0843	CbGeAlD
Ziprasidone—HTR7—autonomic nervous system—metabolic syndrome X	0.00497	0.0579	CbGeAlD
Ziprasidone—HTR2A—sympathetic nervous system—metabolic syndrome X	0.00461	0.0537	CbGeAlD
Ziprasidone—Loose stools—Metformin—metabolic syndrome X	0.00366	0.0446	CcSEcCtD
Ziprasidone—HTR1B—artery—metabolic syndrome X	0.00365	0.0426	CbGeAlD
Ziprasidone—Hypothermia—Metformin—metabolic syndrome X	0.00361	0.044	CcSEcCtD
Ziprasidone—Body temperature decreased—Metformin—metabolic syndrome X	0.00361	0.044	CcSEcCtD
Ziprasidone—HTR1D—artery—metabolic syndrome X	0.00354	0.0412	CbGeAlD
Ziprasidone—Clozapine—FMO3—metabolic syndrome X	0.00328	0.505	CrCbGaD
Ziprasidone—HTR2A—autonomic nervous system—metabolic syndrome X	0.0031	0.0361	CbGeAlD
Ziprasidone—HTR1B—blood vessel—metabolic syndrome X	0.00284	0.0332	CbGeAlD
Ziprasidone—HTR7—artery—metabolic syndrome X	0.00282	0.0328	CbGeAlD
Ziprasidone—HTR1D—blood vessel—metabolic syndrome X	0.00275	0.0321	CbGeAlD
Ziprasidone—HTR7—endothelium—metabolic syndrome X	0.00238	0.0277	CbGeAlD
Ziprasidone—Accidental injury—Metformin—metabolic syndrome X	0.00229	0.0279	CcSEcCtD
Ziprasidone—HTR7—blood vessel—metabolic syndrome X	0.00219	0.0256	CbGeAlD
Ziprasidone—Neuropathy—Metformin—metabolic syndrome X	0.0019	0.0232	CcSEcCtD
Ziprasidone—Lightheadedness—Metformin—metabolic syndrome X	0.00181	0.0221	CcSEcCtD
Ziprasidone—HTR2A—artery—metabolic syndrome X	0.00176	0.0205	CbGeAlD
Ziprasidone—Ear pain—Metformin—metabolic syndrome X	0.00172	0.021	CcSEcCtD
Ziprasidone—ADRA1B—kidney—metabolic syndrome X	0.00164	0.0192	CbGeAlD
Ziprasidone—Injury—Metformin—metabolic syndrome X	0.0016	0.0195	CcSEcCtD
Ziprasidone—H1F0—cardiovascular system—metabolic syndrome X	0.00159	0.0185	CbGeAlD
Ziprasidone—H1F0—kidney—metabolic syndrome X	0.00155	0.0181	CbGeAlD
Ziprasidone—Renal impairment—Metformin—metabolic syndrome X	0.00154	0.0188	CcSEcCtD
Ziprasidone—Hypoglycaemia—Metformin—metabolic syndrome X	0.00151	0.0184	CcSEcCtD
Ziprasidone—Lethargy—Metformin—metabolic syndrome X	0.0015	0.0183	CcSEcCtD
Ziprasidone—HTR2A—endothelium—metabolic syndrome X	0.00148	0.0173	CbGeAlD
Ziprasidone—Pain in extremity—Metformin—metabolic syndrome X	0.00147	0.0179	CcSEcCtD
Ziprasidone—H1F0—adipose tissue—metabolic syndrome X	0.0014	0.0163	CbGeAlD
Ziprasidone—HTR2A—blood vessel—metabolic syndrome X	0.00137	0.016	CbGeAlD
Ziprasidone—Dehydration—Metformin—metabolic syndrome X	0.00137	0.0167	CcSEcCtD
Ziprasidone—Liver function test abnormal—Metformin—metabolic syndrome X	0.00136	0.0165	CcSEcCtD
Ziprasidone—Breast disorder—Metformin—metabolic syndrome X	0.00133	0.0162	CcSEcCtD
Ziprasidone—Cramp muscle—Metformin—metabolic syndrome X	0.00132	0.0161	CcSEcCtD
Ziprasidone—CYP3A7—liver—metabolic syndrome X	0.00132	0.0154	CbGeAlD
Ziprasidone—Nasopharyngitis—Metformin—metabolic syndrome X	0.00131	0.016	CcSEcCtD
Ziprasidone—Aripiprazole—HTR2C—metabolic syndrome X	0.00127	0.195	CrCbGaD
Ziprasidone—Influenza—Metformin—metabolic syndrome X	0.00127	0.0155	CcSEcCtD
Ziprasidone—HTR1B—cardiovascular system—metabolic syndrome X	0.00127	0.0148	CbGeAlD
Ziprasidone—Trazodone—HTR2C—metabolic syndrome X	0.00126	0.195	CrCbGaD
Ziprasidone—CHRM2—cardiovascular system—metabolic syndrome X	0.00126	0.0147	CbGeAlD
Ziprasidone—Sweating increased—Metformin—metabolic syndrome X	0.00124	0.0151	CcSEcCtD
Ziprasidone—Angina pectoris—Metformin—metabolic syndrome X	0.00124	0.0151	CcSEcCtD
Ziprasidone—HTR1D—cardiovascular system—metabolic syndrome X	0.00123	0.0143	CbGeAlD
Ziprasidone—Abdominal discomfort—Metformin—metabolic syndrome X	0.00122	0.0148	CcSEcCtD
Ziprasidone—HTR1D—kidney—metabolic syndrome X	0.0012	0.014	CbGeAlD
Ziprasidone—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.00118	0.0144	CcSEcCtD
Ziprasidone—CHRM1—cardiovascular system—metabolic syndrome X	0.00115	0.0134	CbGeAlD
Ziprasidone—Infestation—Metformin—metabolic syndrome X	0.00113	0.0138	CcSEcCtD
Ziprasidone—Infestation NOS—Metformin—metabolic syndrome X	0.00113	0.0138	CcSEcCtD
Ziprasidone—CYP3A7-CYP3A51P—liver—metabolic syndrome X	0.00112	0.0131	CbGeAlD
Ziprasidone—Neuropathy peripheral—Metformin—metabolic syndrome X	0.00111	0.0135	CcSEcCtD
Ziprasidone—Bradycardia—Metformin—metabolic syndrome X	0.00104	0.0126	CcSEcCtD
Ziprasidone—HTR1A—cardiovascular system—metabolic syndrome X	0.00102	0.0119	CbGeAlD
Ziprasidone—Rhinitis—Metformin—metabolic syndrome X	0.00102	0.0124	CcSEcCtD
Ziprasidone—Hepatitis—Metformin—metabolic syndrome X	0.00102	0.0124	CcSEcCtD
Ziprasidone—Hypoaesthesia—Metformin—metabolic syndrome X	0.00101	0.0123	CcSEcCtD
Ziprasidone—CHRM3—kidney—metabolic syndrome X	0.00101	0.0117	CbGeAlD
Ziprasidone—Oedema peripheral—Metformin—metabolic syndrome X	0.001	0.0122	CcSEcCtD
Ziprasidone—Connective tissue disorder—Metformin—metabolic syndrome X	0.000999	0.0122	CcSEcCtD
Ziprasidone—H1F0—liver—metabolic syndrome X	0.000981	0.0114	CbGeAlD
Ziprasidone—HTR7—cardiovascular system—metabolic syndrome X	0.000979	0.0114	CbGeAlD
Ziprasidone—HTR7—kidney—metabolic syndrome X	0.000957	0.0112	CbGeAlD
Ziprasidone—Eye disorder—Metformin—metabolic syndrome X	0.00095	0.0116	CcSEcCtD
Ziprasidone—ADRA1A—cardiovascular system—metabolic syndrome X	0.000944	0.011	CbGeAlD
Ziprasidone—Cardiac disorder—Metformin—metabolic syndrome X	0.000944	0.0115	CcSEcCtD
Ziprasidone—Angiopathy—Metformin—metabolic syndrome X	0.000922	0.0112	CcSEcCtD
Ziprasidone—Immune system disorder—Metformin—metabolic syndrome X	0.000918	0.0112	CcSEcCtD
Ziprasidone—Mediastinal disorder—Metformin—metabolic syndrome X	0.000916	0.0112	CcSEcCtD
Ziprasidone—Chills—Metformin—metabolic syndrome X	0.000912	0.0111	CcSEcCtD
Ziprasidone—KCNH2—cardiovascular system—metabolic syndrome X	0.000912	0.0106	CbGeAlD
Ziprasidone—CHRM3—adipose tissue—metabolic syndrome X	0.000907	0.0106	CbGeAlD
Ziprasidone—Erythema—Metformin—metabolic syndrome X	0.000885	0.0108	CcSEcCtD
Ziprasidone—Malnutrition—Metformin—metabolic syndrome X	0.000885	0.0108	CcSEcCtD
Ziprasidone—ADRA2C—kidney—metabolic syndrome X	0.00088	0.0103	CbGeAlD
Ziprasidone—Flatulence—Metformin—metabolic syndrome X	0.000872	0.0106	CcSEcCtD
Ziprasidone—Muscle spasms—Metformin—metabolic syndrome X	0.000851	0.0104	CcSEcCtD
Ziprasidone—Vision blurred—Metformin—metabolic syndrome X	0.000834	0.0102	CcSEcCtD
Ziprasidone—ADRA1A—adipose tissue—metabolic syndrome X	0.000832	0.00971	CbGeAlD
Ziprasidone—Tremor—Metformin—metabolic syndrome X	0.000829	0.0101	CcSEcCtD
Ziprasidone—Syncope—Metformin—metabolic syndrome X	0.000794	0.00968	CcSEcCtD
Ziprasidone—ADRA2C—adipose tissue—metabolic syndrome X	0.000793	0.00925	CbGeAlD
Ziprasidone—Palpitations—Metformin—metabolic syndrome X	0.000782	0.00954	CcSEcCtD
Ziprasidone—Loss of consciousness—Metformin—metabolic syndrome X	0.000778	0.00949	CcSEcCtD
Ziprasidone—Hypertension—Metformin—metabolic syndrome X	0.000764	0.00932	CcSEcCtD
Ziprasidone—Myalgia—Metformin—metabolic syndrome X	0.000753	0.00919	CcSEcCtD
Ziprasidone—Chest pain—Metformin—metabolic syndrome X	0.000753	0.00919	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000748	0.00912	CcSEcCtD
Ziprasidone—CYP3A5—kidney—metabolic syndrome X	0.000737	0.00859	CbGeAlD
Ziprasidone—Infection—Metformin—metabolic syndrome X	0.000718	0.00875	CcSEcCtD
Ziprasidone—Shock—Metformin—metabolic syndrome X	0.000711	0.00867	CcSEcCtD
Ziprasidone—Nervous system disorder—Metformin—metabolic syndrome X	0.000708	0.00864	CcSEcCtD
Ziprasidone—Thrombocytopenia—Metformin—metabolic syndrome X	0.000707	0.00862	CcSEcCtD
Ziprasidone—Skin disorder—Metformin—metabolic syndrome X	0.000702	0.00856	CcSEcCtD
Ziprasidone—Hyperhidrosis—Metformin—metabolic syndrome X	0.000698	0.00851	CcSEcCtD
Ziprasidone—Anorexia—Metformin—metabolic syndrome X	0.000689	0.0084	CcSEcCtD
Ziprasidone—Clozapine—HTR2C—metabolic syndrome X	0.000683	0.105	CrCbGaD
Ziprasidone—Hypotension—Metformin—metabolic syndrome X	0.000675	0.00823	CcSEcCtD
Ziprasidone—CYP3A5—adipose tissue—metabolic syndrome X	0.000664	0.00774	CbGeAlD
Ziprasidone—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000658	0.00802	CcSEcCtD
Ziprasidone—Paraesthesia—Metformin—metabolic syndrome X	0.000649	0.00791	CcSEcCtD
Ziprasidone—HRH1—adipose tissue—metabolic syndrome X	0.000644	0.00751	CbGeAlD
Ziprasidone—Dyspnoea—Metformin—metabolic syndrome X	0.000644	0.00785	CcSEcCtD
Ziprasidone—Somnolence—Metformin—metabolic syndrome X	0.000642	0.00783	CcSEcCtD
Ziprasidone—Dyspepsia—Metformin—metabolic syndrome X	0.000636	0.00775	CcSEcCtD
Ziprasidone—ADRA2A—adipose tissue—metabolic syndrome X	0.000633	0.00738	CbGeAlD
Ziprasidone—Decreased appetite—Metformin—metabolic syndrome X	0.000628	0.00766	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000624	0.0076	CcSEcCtD
Ziprasidone—Fatigue—Metformin—metabolic syndrome X	0.000623	0.00759	CcSEcCtD
Ziprasidone—Constipation—Metformin—metabolic syndrome X	0.000618	0.00753	CcSEcCtD
Ziprasidone—HTR2A—cardiovascular system—metabolic syndrome X	0.00061	0.00712	CbGeAlD
Ziprasidone—HTR7—liver—metabolic syndrome X	0.000605	0.00706	CbGeAlD
Ziprasidone—HTR2A—kidney—metabolic syndrome X	0.000597	0.00696	CbGeAlD
Ziprasidone—Feeling abnormal—Metformin—metabolic syndrome X	0.000595	0.00726	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000591	0.0072	CcSEcCtD
Ziprasidone—ADRA1A—liver—metabolic syndrome X	0.000584	0.00681	CbGeAlD
Ziprasidone—Urticaria—Metformin—metabolic syndrome X	0.000574	0.007	CcSEcCtD
Ziprasidone—Abdominal pain—Metformin—metabolic syndrome X	0.000571	0.00696	CcSEcCtD
Ziprasidone—ADRA2C—liver—metabolic syndrome X	0.000556	0.00649	CbGeAlD
Ziprasidone—CYP3A4—kidney—metabolic syndrome X	0.000553	0.00645	CbGeAlD
Ziprasidone—CYP2D6—kidney—metabolic syndrome X	0.000544	0.00634	CbGeAlD
Ziprasidone—Asthenia—Metformin—metabolic syndrome X	0.000518	0.00632	CcSEcCtD
Ziprasidone—Diarrhoea—Metformin—metabolic syndrome X	0.000494	0.00603	CcSEcCtD
Ziprasidone—CYP1A2—liver—metabolic syndrome X	0.000483	0.00563	CbGeAlD
Ziprasidone—Dizziness—Metformin—metabolic syndrome X	0.000478	0.00582	CcSEcCtD
Ziprasidone—CYP3A5—liver—metabolic syndrome X	0.000466	0.00543	CbGeAlD
Ziprasidone—Vomiting—Metformin—metabolic syndrome X	0.000459	0.0056	CcSEcCtD
Ziprasidone—Rash—Metformin—metabolic syndrome X	0.000455	0.00555	CcSEcCtD
Ziprasidone—Dermatitis—Metformin—metabolic syndrome X	0.000455	0.00555	CcSEcCtD
Ziprasidone—Headache—Metformin—metabolic syndrome X	0.000453	0.00552	CcSEcCtD
Ziprasidone—Nausea—Metformin—metabolic syndrome X	0.000429	0.00523	CcSEcCtD
Ziprasidone—HTR2A—liver—metabolic syndrome X	0.000377	0.0044	CbGeAlD
Ziprasidone—CYP3A4—liver—metabolic syndrome X	0.000349	0.00407	CbGeAlD
Ziprasidone—CYP2D6—liver—metabolic syndrome X	0.000344	0.00401	CbGeAlD
Ziprasidone—CHRM5—GPCR downstream signaling—AKT1—metabolic syndrome X	9.5e-06	5.35e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—IRS1—metabolic syndrome X	9.5e-06	5.35e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—LIPC—metabolic syndrome X	9.49e-06	5.35e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GCK—metabolic syndrome X	9.49e-06	5.35e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling by GPCR—AKT1—metabolic syndrome X	9.48e-06	5.34e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—SERPINE1—metabolic syndrome X	9.47e-06	5.34e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—APOC3—metabolic syndrome X	9.43e-06	5.32e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—APOA1—metabolic syndrome X	9.42e-06	5.31e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—NOS3—metabolic syndrome X	9.41e-06	5.3e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling by GPCR—IL6—metabolic syndrome X	9.35e-06	5.27e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—IRS1—metabolic syndrome X	9.34e-06	5.27e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—IRS1—metabolic syndrome X	9.32e-06	5.26e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—NOS3—metabolic syndrome X	9.31e-06	5.25e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—IRS1—metabolic syndrome X	9.29e-06	5.24e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling by GPCR—AKT1—metabolic syndrome X	9.28e-06	5.23e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—APOB—metabolic syndrome X	9.28e-06	5.23e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—IRS1—metabolic syndrome X	9.27e-06	5.22e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—GGT1—metabolic syndrome X	9.26e-06	5.22e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—GOT1—metabolic syndrome X	9.26e-06	5.22e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—SERPINE1—metabolic syndrome X	9.21e-06	5.19e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—IRS1—metabolic syndrome X	9.18e-06	5.17e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—CETP—metabolic syndrome X	9.16e-06	5.16e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—IRS1—metabolic syndrome X	9.15e-06	5.16e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling by GPCR—AKT1—metabolic syndrome X	9.13e-06	5.15e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—PPARG—metabolic syndrome X	9.1e-06	5.13e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—INS—metabolic syndrome X	9.1e-06	5.13e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—NOS3—metabolic syndrome X	9.08e-06	5.12e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—SERPINE1—metabolic syndrome X	9.06e-06	5.11e-05	CbGpPWpGaD
Ziprasidone—DRD1—GPCR downstream signaling—AKT1—metabolic syndrome X	9.05e-06	5.1e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—NOS3—metabolic syndrome X	9.04e-06	5.09e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	9.03e-06	5.09e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling by GPCR—AKT1—metabolic syndrome X	9.01e-06	5.08e-05	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—IL6—metabolic syndrome X	8.95e-06	5.05e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—INS—metabolic syndrome X	8.95e-06	5.04e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CCL2—metabolic syndrome X	8.95e-06	5.04e-05	CbGpPWpGaD
Ziprasidone—DRD3—GPCR downstream signaling—AKT1—metabolic syndrome X	8.93e-06	5.03e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—INS—metabolic syndrome X	8.93e-06	5.03e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—ALB—metabolic syndrome X	8.93e-06	5.03e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—INS—metabolic syndrome X	8.92e-06	5.03e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling by GPCR—IL6—metabolic syndrome X	8.91e-06	5.02e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—INS—metabolic syndrome X	8.9e-06	5.02e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—INS—metabolic syndrome X	8.87e-06	5e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—LPL—metabolic syndrome X	8.86e-06	4.99e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CCL2—metabolic syndrome X	8.81e-06	4.96e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—IGF1—metabolic syndrome X	8.8e-06	4.96e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling by GPCR—IL6—metabolic syndrome X	8.79e-06	4.96e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—NOS3—metabolic syndrome X	8.79e-06	4.95e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—INS—metabolic syndrome X	8.79e-06	4.95e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CCL2—metabolic syndrome X	8.79e-06	4.95e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	8.77e-06	4.94e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—INS—metabolic syndrome X	8.76e-06	4.94e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CCL2—metabolic syndrome X	8.76e-06	4.94e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CCL2—metabolic syndrome X	8.73e-06	4.92e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—IGF1—metabolic syndrome X	8.66e-06	4.88e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—NOS3—metabolic syndrome X	8.65e-06	4.88e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CCL2—metabolic syndrome X	8.65e-06	4.87e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—IGF1—metabolic syndrome X	8.64e-06	4.87e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling by GPCR—AKT1—metabolic syndrome X	8.63e-06	4.86e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CCL2—metabolic syndrome X	8.62e-06	4.86e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—IGF1—metabolic syndrome X	8.61e-06	4.85e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—IGF1—metabolic syndrome X	8.58e-06	4.84e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—NOS3—metabolic syndrome X	8.54e-06	4.81e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	8.51e-06	4.8e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—PTGS2—metabolic syndrome X	8.51e-06	4.8e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IRS1—metabolic syndrome X	8.5e-06	4.79e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—IGF1—metabolic syndrome X	8.5e-06	4.79e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—IGF1—metabolic syndrome X	8.48e-06	4.78e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—CD36—metabolic syndrome X	8.42e-06	4.75e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—SERPINE1—metabolic syndrome X	8.35e-06	4.71e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GOT2—metabolic syndrome X	8.28e-06	4.67e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	8.28e-06	4.67e-05	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—AKT1—metabolic syndrome X	8.26e-06	4.65e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling by GPCR—AKT1—metabolic syndrome X	8.22e-06	4.63e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—SERPINE1—metabolic syndrome X	8.22e-06	4.63e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—SERPINE1—metabolic syndrome X	8.2e-06	4.62e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—ALB—metabolic syndrome X	8.18e-06	4.61e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—SERPINE1—metabolic syndrome X	8.18e-06	4.61e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—SERPINE1—metabolic syndrome X	8.15e-06	4.59e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—INS—metabolic syndrome X	8.14e-06	4.59e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—TGFB1—metabolic syndrome X	8.11e-06	4.57e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling by GPCR—AKT1—metabolic syndrome X	8.11e-06	4.57e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—TGFB1—metabolic syndrome X	8.11e-06	4.57e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—SERPINE1—metabolic syndrome X	8.07e-06	4.55e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—GPCR downstream signaling—AKT1—metabolic syndrome X	8.06e-06	4.55e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—TGFB1—metabolic syndrome X	8.05e-06	4.54e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—SERPINE1—metabolic syndrome X	8.05e-06	4.54e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CCL2—metabolic syndrome X	8.01e-06	4.52e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—NOS3—metabolic syndrome X	7.98e-06	4.5e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling by GPCR—IL6—metabolic syndrome X	7.94e-06	4.47e-05	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—IL6—metabolic syndrome X	7.92e-06	4.47e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—TGFB1—metabolic syndrome X	7.89e-06	4.44e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IGF1—metabolic syndrome X	7.88e-06	4.44e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—APOB—metabolic syndrome X	7.86e-06	4.43e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—NOS3—metabolic syndrome X	7.85e-06	4.42e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—NOS3—metabolic syndrome X	7.83e-06	4.41e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PPARA—metabolic syndrome X	7.83e-06	4.41e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—NOS3—metabolic syndrome X	7.82e-06	4.41e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—PTGS2—metabolic syndrome X	7.81e-06	4.4e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—NOS3—metabolic syndrome X	7.81e-06	4.4e-05	CbGpPWpGaD
Ziprasidone—HTR1A—GPCR downstream signaling—AKT1—metabolic syndrome X	7.78e-06	4.39e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—NOS3—metabolic syndrome X	7.78e-06	4.39e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—TGFB1—metabolic syndrome X	7.76e-06	4.37e-05	CbGpPWpGaD
Ziprasidone—HTR2C—GPCR downstream signaling—AKT1—metabolic syndrome X	7.74e-06	4.36e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—NOS3—metabolic syndrome X	7.71e-06	4.34e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—NOS3—metabolic syndrome X	7.68e-06	4.33e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—IL6—metabolic syndrome X	7.66e-06	4.32e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—TGFB1—metabolic syndrome X	7.66e-06	4.31e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	7.65e-06	4.31e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—IL6—metabolic syndrome X	7.62e-06	4.3e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—AGT—metabolic syndrome X	7.58e-06	4.27e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—GPCR downstream signaling—AKT1—metabolic syndrome X	7.53e-06	4.25e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—LPL—metabolic syndrome X	7.51e-06	4.23e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—SERPINE1—metabolic syndrome X	7.48e-06	4.22e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—APOE—metabolic syndrome X	7.43e-06	4.19e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—IL6—metabolic syndrome X	7.41e-06	4.18e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—GPCR downstream signaling—AKT1—metabolic syndrome X	7.41e-06	4.18e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	7.38e-06	4.16e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	7.38e-06	4.16e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—APOA1—metabolic syndrome X	7.34e-06	4.14e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—TGFB1—metabolic syndrome X	7.33e-06	4.13e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling by GPCR—AKT1—metabolic syndrome X	7.32e-06	4.13e-05	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—AKT1—metabolic syndrome X	7.31e-06	4.12e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—IL6—metabolic syndrome X	7.3e-06	4.11e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—PTGS2—metabolic syndrome X	7.16e-06	4.03e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GOT1—metabolic syndrome X	7.15e-06	4.03e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GGT1—metabolic syndrome X	7.15e-06	4.03e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—NOS3—metabolic syndrome X	7.14e-06	4.02e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—CD36—metabolic syndrome X	7.13e-06	4.02e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—AKT1—metabolic syndrome X	7.07e-06	3.98e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—AKT1—metabolic syndrome X	7.03e-06	3.96e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—TGFB1—metabolic syndrome X	6.99e-06	3.94e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—TGFB1—metabolic syndrome X	6.89e-06	3.88e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—AKT1—metabolic syndrome X	6.84e-06	3.86e-05	CbGpPWpGaD
Ziprasidone—DRD2—GPCR downstream signaling—AKT1—metabolic syndrome X	6.83e-06	3.85e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—AKT1—metabolic syndrome X	6.73e-06	3.79e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—IL6—metabolic syndrome X	6.73e-06	3.79e-05	CbGpPWpGaD
Ziprasidone—HTR2A—GPCR downstream signaling—AKT1—metabolic syndrome X	6.72e-06	3.79e-05	CbGpPWpGaD
Ziprasidone—HRH1—GPCR downstream signaling—AKT1—metabolic syndrome X	6.71e-06	3.78e-05	CbGpPWpGaD
Ziprasidone—CHRM1—GPCR downstream signaling—AKT1—metabolic syndrome X	6.69e-06	3.77e-05	CbGpPWpGaD
Ziprasidone—CHRM3—GPCR downstream signaling—AKT1—metabolic syndrome X	6.67e-06	3.76e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PPARA—metabolic syndrome X	6.63e-06	3.74e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—IL6—metabolic syndrome X	6.62e-06	3.73e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—IL6—metabolic syndrome X	6.61e-06	3.72e-05	CbGpPWpGaD
Ziprasidone—CHRM2—GPCR downstream signaling—AKT1—metabolic syndrome X	6.6e-06	3.72e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—GPCR downstream signaling—AKT1—metabolic syndrome X	6.58e-06	3.71e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—IL6—metabolic syndrome X	6.58e-06	3.71e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—IL6—metabolic syndrome X	6.56e-06	3.7e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—IL6—metabolic syndrome X	6.5e-06	3.66e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—IL6—metabolic syndrome X	6.48e-06	3.65e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PPARG—metabolic syndrome X	6.47e-06	3.65e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—AGT—metabolic syndrome X	6.42e-06	3.62e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—INS—metabolic syndrome X	6.34e-06	3.58e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—APOE—metabolic syndrome X	6.29e-06	3.55e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—TGFB1—metabolic syndrome X	6.22e-06	3.51e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—APOA1—metabolic syndrome X	6.22e-06	3.51e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—AKT1—metabolic syndrome X	6.21e-06	3.5e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—GPCR downstream signaling—AKT1—metabolic syndrome X	6.12e-06	3.45e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—IL6—metabolic syndrome X	6.11e-06	3.45e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—IL6—metabolic syndrome X	6.11e-06	3.44e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—AKT1—metabolic syndrome X	6.11e-06	3.44e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—AKT1—metabolic syndrome X	6.09e-06	3.43e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—AKT1—metabolic syndrome X	6.07e-06	3.42e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—IL6—metabolic syndrome X	6.07e-06	3.42e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—APOB—metabolic syndrome X	6.07e-06	3.42e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—AKT1—metabolic syndrome X	6.05e-06	3.41e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—IL6—metabolic syndrome X	6.02e-06	3.39e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—TGFB1—metabolic syndrome X	6.01e-06	3.39e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—AKT1—metabolic syndrome X	6e-06	3.38e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—AKT1—metabolic syndrome X	5.98e-06	3.37e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—TGFB1—metabolic syndrome X	5.98e-06	3.37e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—IL6—metabolic syndrome X	5.94e-06	3.35e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	5.9e-06	3.33e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—IL6—metabolic syndrome X	5.85e-06	3.3e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—ALB—metabolic syndrome X	5.82e-06	3.28e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—TGFB1—metabolic syndrome X	5.81e-06	3.28e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—LPL—metabolic syndrome X	5.79e-06	3.27e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—IL6—metabolic syndrome X	5.77e-06	3.25e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—TGFB1—metabolic syndrome X	5.72e-06	3.22e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—AKT1—metabolic syndrome X	5.64e-06	3.18e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—AKT1—metabolic syndrome X	5.64e-06	3.18e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—AKT1—metabolic syndrome X	5.6e-06	3.16e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—NOS3—metabolic syndrome X	5.56e-06	3.14e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—AKT1—metabolic syndrome X	5.56e-06	3.13e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—IL6—metabolic syndrome X	5.52e-06	3.11e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—CD36—metabolic syndrome X	5.5e-06	3.1e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—AKT1—metabolic syndrome X	5.48e-06	3.09e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PPARG—metabolic syndrome X	5.48e-06	3.09e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—AKT1—metabolic syndrome X	5.39e-06	3.04e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—INS—metabolic syndrome X	5.37e-06	3.03e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—AKT1—metabolic syndrome X	5.32e-06	3e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—TGFB1—metabolic syndrome X	5.27e-06	2.97e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—IL6—metabolic syndrome X	5.26e-06	2.97e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—IL6—metabolic syndrome X	5.19e-06	2.93e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—TGFB1—metabolic syndrome X	5.19e-06	2.92e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—TGFB1—metabolic syndrome X	5.18e-06	2.92e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—TGFB1—metabolic syndrome X	5.16e-06	2.91e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—TGFB1—metabolic syndrome X	5.15e-06	2.9e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PPARA—metabolic syndrome X	5.12e-06	2.88e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—AKT1—metabolic syndrome X	5.1e-06	2.87e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—TGFB1—metabolic syndrome X	5.1e-06	2.87e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	5.09e-06	2.87e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—TGFB1—metabolic syndrome X	5.08e-06	2.86e-05	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—AKT1—metabolic syndrome X	4.98e-06	2.8e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—AGT—metabolic syndrome X	4.96e-06	2.79e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—ALB—metabolic syndrome X	4.93e-06	2.78e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—AKT1—metabolic syndrome X	4.86e-06	2.74e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—APOE—metabolic syndrome X	4.86e-06	2.74e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—AKT1—metabolic syndrome X	4.83e-06	2.72e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—APOA1—metabolic syndrome X	4.8e-06	2.71e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—AKT1—metabolic syndrome X	4.79e-06	2.7e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—TGFB1—metabolic syndrome X	4.72e-06	2.66e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—NOS3—metabolic syndrome X	4.71e-06	2.66e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—IL6—metabolic syndrome X	4.69e-06	2.64e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—IL6—metabolic syndrome X	4.53e-06	2.55e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—IL6—metabolic syndrome X	4.5e-06	2.54e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—IL6—metabolic syndrome X	4.38e-06	2.47e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—AKT1—metabolic syndrome X	4.33e-06	2.44e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	4.31e-06	2.43e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—IL6—metabolic syndrome X	4.31e-06	2.43e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—AKT1—metabolic syndrome X	4.28e-06	2.41e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PPARG—metabolic syndrome X	4.23e-06	2.38e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—AKT1—metabolic syndrome X	4.18e-06	2.35e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—AKT1—metabolic syndrome X	4.15e-06	2.34e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—INS—metabolic syndrome X	4.15e-06	2.34e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—AKT1—metabolic syndrome X	4.04e-06	2.28e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—AKT1—metabolic syndrome X	3.98e-06	2.24e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—IL6—metabolic syndrome X	3.97e-06	2.24e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—AKT1—metabolic syndrome X	3.93e-06	2.21e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—IL6—metabolic syndrome X	3.91e-06	2.2e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—IL6—metabolic syndrome X	3.9e-06	2.2e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—IL6—metabolic syndrome X	3.89e-06	2.19e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—IL6—metabolic syndrome X	3.88e-06	2.19e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—IL6—metabolic syndrome X	3.84e-06	2.16e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—IL6—metabolic syndrome X	3.83e-06	2.16e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—ALB—metabolic syndrome X	3.8e-06	2.14e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—AKT1—metabolic syndrome X	3.67e-06	2.07e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—NOS3—metabolic syndrome X	3.64e-06	2.05e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—AKT1—metabolic syndrome X	3.61e-06	2.03e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—AKT1—metabolic syndrome X	3.6e-06	2.03e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—AKT1—metabolic syndrome X	3.6e-06	2.03e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—AKT1—metabolic syndrome X	3.59e-06	2.02e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—AKT1—metabolic syndrome X	3.58e-06	2.02e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IL6—metabolic syndrome X	3.56e-06	2.01e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—AKT1—metabolic syndrome X	3.54e-06	2e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—AKT1—metabolic syndrome X	3.53e-06	1.99e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	3.33e-06	1.88e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—AKT1—metabolic syndrome X	3.28e-06	1.85e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—AKT1—metabolic syndrome X	2.56e-06	1.44e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—AKT1—metabolic syndrome X	2.17e-06	1.22e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—AKT1—metabolic syndrome X	1.67e-06	9.43e-06	CbGpPWpGaD
